Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Outcome in breast cancer managed without an initial axillary lymph node dissection

A Sun1, F F Liu, M Pintilie

  • 1Department of Radiation Oncology, Nova Scotia Cancer Center, Halifax, Canada.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|October 23, 1998
PubMed
Summary

For early-stage breast cancer patients, delaying axillary lymph node dissection (AxLND) is safe. A study found that not performing an initial AxLND did not negatively impact survival or recurrence rates in selected women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Jejunal undifferentiated carcinoma with multiple metastases involving the right palatine tonsil: a case report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2026
Same author

Copper-catalyzed three-component thiocyanosulfonylation of allenes.

Chemical communications (Cambridge, England)·2026
Same author

Toxicological Evaluation of Vanillin Flavor in E-Liquid Aerosols on Endothelial Cell Function: Findings from the Replica Project.

Cardiovascular toxicology·2026
Same author

[Epidemiological characteristics of typhoid fever and paratyphoid fever outbreaks in China from 2008 to 2024].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026
Same author

[Efficiency and safety of JAK inhibitors for alopecia totalis and alopecia universalis].

Zhonghua yi xue za zhi·2025
Same author

[Genomic profiles of primary and acquired MET mutations in NSCLC and the impact of co-mutations on treatment outcomes].

Zhonghua yi xue za zhi·2025

Area of Science:

  • Oncology
  • Surgical Oncology

Background:

  • The necessity of elective axillary lymph node dissection (AxLND) in early-stage breast cancer management is debated.
  • Patient selection and outcomes for those not undergoing initial AxLND require further investigation.

Purpose of the Study:

  • To review the reasons for omitting initial AxLND in early-stage breast cancer patients at a single institution.
  • To evaluate the survival and recurrence rates for these patients.

Main Methods:

  • Retrospective analysis of 126 women with breast cancer who did not undergo initial AxLND.
  • Data collected on patient demographics, tumor characteristics, adjuvant therapies, and outcomes.

Main Results:

  • The 5-year survival rate was 92%, with 85% local relapse-free and 86% axillary relapse-free rates.

Related Experiment Videos

  • Reasons for omitting AxLND included patient age, medical contraindications, or patient choice (approx. one-third of cases).
  • Only 13% of patients required a subsequent AxLND, with no debilitating axillary symptoms reported.

    • Conclusions:

    • Delayed axillary lymph node dissection (AxLND) is a viable option for selected early-stage breast cancer patients.
    • Omitting initial AxLND does not compromise patient outcomes regarding survival and recurrence.